RHHBY(RHHBY)
RHHBY
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $61.49B | $64.16B | $67.23B | $71.05B | $74.02B |
| Low | $60.20B | $61.78B | $65.46B | $69.18B | $72.07B |
| High | $64.04B | $67.24B | $70.32B | $74.32B | $77.42B |
| EBITDA Avg | $20.08B | $20.95B | $21.95B | $23.20B | $24.17B |
| Low | $19.66B | $20.17B | $21.37B | $22.59B | $23.53B |
| High | $20.91B | $21.95B | $22.96B | $24.27B | $25.28B |
| EBIT Avg | $16.51B | $17.23B | $18.06B | $19.08B | $19.88B |
| Low | $16.17B | $16.59B | $17.58B | $18.58B | $19.36B |
| High | $17.20B | $18.06B | $18.89B | $19.96B | $20.80B |
| Net Income Avg | $15.85B | $17.10B | $18.53B | $20.62B | $22.60B |
| Low | $13.41B | $14.44B | $17.89B | $19.91B | $21.83B |
| High | $16.63B | $17.99B | $19.64B | $21.85B | $23.95B |
| EPS Avg | $2.47 | $2.66 | $2.88 | $3.21 | $3.52 |
| Low | $2.09 | $2.25 | $2.79 | $3.10 | $3.40 |
| High | $2.59 | $2.80 | $3.06 | $3.40 | $3.73 |
| Analysts (Rev / EPS) | 9 / 5 | 10 / 5 | 4 / 2 | 5 / 1 | 5 / 1 |
| Metric | Q4 2026 |
|---|---|
| Revenue Avg | $13.00B |
| Low | $12.95B |
| High | $13.06B |
| EBITDA Avg | $4.25B |
| Low | $4.23B |
| High | $4.26B |
| EBIT Avg | $3.49B |
| Low | $3.48B |
| High | $3.51B |
| Net Income Avg | — |
| Low | — |
| High | — |
| EPS Avg | — |
| Low | — |
| High | — |
| Analysts (Rev / EPS) | 2 / — |